-
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al DC CAFC
- 2:10-cv-05954
- D.N.J.
- Judge: William H. Walls +4
- Filed: 11/15/2010
- Closed: 08/19/2014
- Latest Docket Entry: 06/21/2016
- PACER
- Docket updated daily
6
Plaintiffs
6
Defendants
1
Accused
Product
4
Patents-in-Suit
1,374
Days in
Litigation
-
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al DC CAFC
- 2:10-cv-05954
- D.N.J.
- Judge: William H. Walls +4
- Filed: 11/15/2010
- Closed: 08/19/2014
- Latest Docket Entry: 06/21/2016
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Referred Judges
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
13 |
A process according to claim 2 wherein (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol is reacted with bis-(4-nitrophenyl)carbonate before coupling to compound of formula (5).
|
Valid (103 and 112)
Entry 998 |
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for the synthesis of hexahydro-furo[2,3-b]furan-3-ol of formula (7) starting from an intermediate of formula (1) wherein P<sup>1 </sup>and P<sup>2 </sup>represent each independently a hydrogen, a hydroxy-protecting group or may together form
view more
|
Valid (103 and 112)
Entry 998 |
Claim | Outcome |
---|---|
All challenged claims |
Enforceable and Valid
Entry 804 |
-
Infringement
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol | US 7,126,015 B2 |
1
|
Infringement
Entry 998
|
Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate | US 7,772,411 B2 |
13
|
Infringement
Entry 998
|
Cipla (EU) Limited
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol | US 7,126,015 B2 |
1
|
Infringement
Entry 998
|
Generic PREZISTA tablets 150 mgGeneric PREZISTA tablets 300 mgGeneric PREZISTA tablets 400 mgGeneric PREZISTA tablets 600mgGeneric PREZISTA tablets 75 mgProcess for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate | US 7,772,411 B2 |
13
|
Infringement
Entry 770Entry 998 |
Mylan Incorporated
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol | US 7,126,015 B2 |
1
|
Infringement
Entry 998
|
Generic PREZISTA tablets 150 mgGeneric PREZISTA tablets 300 mgGeneric PREZISTA tablets 400 mgGeneric PREZISTA tablets 600mgGeneric PREZISTA tablets 75 mgProcess for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate | US 7,772,411 B2 |
13
|
Infringement
Entry 770Entry 998 |
Mylan Pharmaceuticals Incorporated
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol | US 7,126,015 B2 |
1
|
Infringement
Entry 998
|
Generic PREZISTA tablets 150 mgGeneric PREZISTA tablets 300 mgGeneric PREZISTA tablets 400 mgGeneric PREZISTA tablets 600mgGeneric PREZISTA tablets 75 mgProcess for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate | US 7,772,411 B2 |
13
|
Infringement
Entry 770Entry 998 |